Meeting
2024 ASCO Genitourinary Cancers Symposium
The impact of SPOP gene alterations in men with metastatic prostate cancer: Results from the Prostate Cancer Precision Medicine Multi-Institutional Collaborative Effort (PROMISE) consortium.
Authors
Kyra Lee Yamamoto
Moores Cancer Center at UC San Diego Health, La Jolla, CA
Kyra Lee Yamamoto , Nicholas Henderson , Clara Hwang , Pedro C. Barata , Mehmet Asim Bilen , Deepak Kilari , Laura Graham , Rohan Garje , Shoshana Rothstein , Vadim S Koshkin , Abhishek Tripathi , Frank Cameron Cackowski , Jones T. Nauseef , Michael Thomas Schweizer , Andrew J. Armstrong , Tanya B. Dorff , Ajjai Shivaram Alva , Rana R. McKay
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Other
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 225)
DOI
10.1200/JCO.2024.42.4_suppl.225
Abstract #
225
Poster Bd #
K13
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Canonical Wnt signaling pathway (WSP) alterations in metastatic prostate cancer.
First Author: Sharon Choi
Poster
2024 ASCO Genitourinary Cancers Symposium
Impact of TP53, RB1, and PTEN mutations on overall survival in metastatic prostate cancer: A multi-center study via the Guardian Research Network.
First Author: Mohammad Arfat Ganiyani
Poster
2023 ASCO Genitourinary Cancers Symposium
Comparative outcomes of metastatic prostate cancer (mPC) patients (pts) with DNA damage response gene alterations (DDR-a): A single-center experience.
First Author: Khalid Almunaikh
Poster
2023 ASCO Genitourinary Cancers Symposium
Role of adenomatous polyposis coli (APC) gene in SPOP-mutant prostate cancer and clinical outcomes.
First Author: Shamis Khan